Get Live Data

Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE
GreenRoc Accelerates their World Class Project to Production as Early as 2028
GreenRoc Accelerates their World Class Project to Production as Early as 2028View Video

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share News
  5. IN BRIEF: BioPharma Credit receives USD175 million from Pfizer deal

Pin to quick picksBiopharma Cred. Share News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.842
Bid: 0.842
Ask: 0.846
Change: 0.002 (0.24%)
Spread: 0.004 (0.475%)
Open: 0.842
High: 0.844
Low: 0.842
Prev. Close: 0.84
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: BioPharma Credit receives USD175 million from Pfizer deal

Thu, 06th Oct 2022 12:59

Biopharma Credit PLC - New York-based life sciences debt investment trust - Company's investment manager, Pharmakon Advisors, notes the announcement made by Pfizer Inc on Wednesday about acquisition of Global Blood Therapeutics for USD5.4 billion. BioPharma had USD132.5 million investment in Global Blood Therapeutics in a senior secured loan which has been prepaid following the acquisition. The senior secured loan was invested through three different tranches. In total the company received USD175.4 million, including USD42.9 million of accrued interest, paydown, prepayment and make-whole fees, realising an internal rate of return of 28%.

Current stock price: 85.54 pence

12-month change: up 19%

By Chris Dorrell; chrisdorrell@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2018 11:33

BioPharma Credit Increases Placing Size To USD200 Million (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Wednesday it increased the size of its proposed placing to "at least" USD200 million due to strong investor demand.Last Friday,

Read more
24 Oct 2018 09:02

BioPharma Credit increases placing following 'strong investor demand'

(Sharecast News) - BioPharma Credit has increased the size of its proposed placing to "at least" $200m on the back of investor demand that exceeded its original target.

Read more
19 Oct 2018 11:26

BioPharma Credit To Raise USD150 Million Via Placing (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million shares at USD1.025 per share, a 2.9% to a

Read more
27 Sep 2018 12:43

BioPharma Credit Interim Net Asset Value Flat, Income Rises Sharply

LONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life sciences debt investment trust increased to

Read more
20 Sep 2018 13:31

BioPharma Credit Loans USD150 Million To Amicus Therapeutics

LONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-focused biopharmaceutical company.Under in

Read more
2 Jul 2018 12:55

BioPharma Funds USD200 Million TESARO Loan Alongside Other Investors

LONDON (Alliance News) - BioPharma Credit PLC said Monday it has funded, alongside other investors, the USD200 million second tranche of a USD500 million loan to TESARO Inc.The company and

Read more
4 May 2018 12:26

Pablo Legorreta Doubles BioPharma Credit Stake To 7.1% (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday Pablo Legorreta doubled his stake in the pharmaceutical debt investor in a transaction on Monday.Legorreta - the founder and chief

Read more
2 May 2018 16:51

Pharmaceutical Investors Cuts BioPharma Credit Stake Below 3% (ALLISS)

LONDON (Alliance News) - Life-science focused debt investor BioPharma Credit PLC said on Wednesday Pharmaceutical Investors LP sold shares in the company on Tuesday.After the transaction a

Read more
1 May 2018 16:26

BioPharma Invests USD194 Million In US Pharma Firm Sebela

LONDON (Alliance News) - BioPharma Credit PLC said Tuesday that it has invested USD194 million in a unit of US-based Sebela Pharmaceuticals Inc.The life science-focused debt investor has a

Read more
23 Apr 2018 13:06

BioPharma Credit To Invest USD191 Million In Pharmaceutical Developer

LONDON (Alliance News) - Life science-focused debt investor BioPharma Credit PLC said on Monday it has become the lead investor and collateral agent for a USD315.0 million loan to an unnamed will

Read more
8 Mar 2018 12:21

BioPharma Credit To Raise USD300 Million As Net Asset Value Rises (ALLISS)

LONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC said Thursday it has had a "highly successful" 2017 and announced a share issue to raise on

Read more
1234567

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.